0001826133-21-000002.txt : 20210111
0001826133-21-000002.hdr.sgml : 20210111
20210111164013
ACCESSION NUMBER: 0001826133-21-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210108
FILED AS OF DATE: 20210111
DATE AS OF CHANGE: 20210111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parkinson Paul
CENTRAL INDEX KEY: 0001826133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 21521245
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-01-08
0
0000899923
MYRIAD GENETICS INC
MYGN
0001826133
Parkinson Paul
320 WAKARA WAY
SALT LAKE CITY
UT
84108
0
1
0
0
EVP Strategy and Innovation
Common Stock
2021-01-08
4
S
0
11824
25.0
D
76746
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
By: Nathan A. Smith For: Paul Parkinson
2021-01-11